A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care
Description
CONCLUSION: Results do not prove the use of domperidone as antiviral in patients with COVID-19.
